These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2351565)

  • 41. Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions.
    Gervois N; Guilloux Y; Diez E; Jotereau F
    J Exp Med; 1996 May; 183(5):2403-7. PubMed ID: 8642353
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactions.
    Radrizzani M; Benedetti B; Castelli C; Longo A; Ferrara GB; Herlyn M; Parmiani G; Fossati G
    Int J Cancer; 1991 Dec; 49(6):823-30. PubMed ID: 1835714
    [TBL] [Abstract][Full Text] [Related]  

  • 43. T cell receptor gene rearrangements and cytotoxic activities of clones isolated from tumour-infiltrating lymphocytes (TIL) from melanoma patients.
    Pandolfi F; Boyle LA; Trentin L; Oliva A; Kurnick JT
    Clin Exp Immunol; 1994 Jan; 95(1):141-7. PubMed ID: 8287599
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential expression of inhibitory or activating CD94/NKG2 subtypes on MART-1-reactive T cells in vitiligo versus melanoma: a case report.
    Pedersen LØ; Vetter CS; Mingari MC; Andersen MH; thor Straten P; Bröcker EB; Becker JC
    J Invest Dermatol; 2002 Apr; 118(4):595-9. PubMed ID: 11918704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor-specific T-cell clones recognize different protein determinants of autologous human malignant melanoma cells.
    Notter M; Schirrmacher V
    Int J Cancer; 1990 May; 45(5):834-41. PubMed ID: 2159436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monoclonal antibodies to human melanoma associated antigens: study of their specificity and visualization at the cellular level of the antigenic distribution.
    Libert A; Ghanem G; Arnould R; Vercammen-Grandjean A; Carrel S; Lejeune F
    Anticancer Res; 1983; 3(4):219-25. PubMed ID: 6576727
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased sensitivity to MHC-nonrestricted lysis of BL6 melanoma cells by transfection with class I H-2Kb gene.
    Gorelik E; Jay G; Kwiatkowski B; Herberman RB
    J Immunol; 1990 Sep; 145(5):1621-32. PubMed ID: 2384672
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.
    Rivoltini L; Radrizzani M; Accornero P; Squarcina P; Chiodoni C; Mazzocchi A; Castelli C; Tarsini P; Viggiano V; Belli F; Colombo MP; Parmiani G
    J Immunol; 1998 Aug; 161(3):1220-30. PubMed ID: 9686582
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytolytic T-cell clones define HLA-A2-restricted human cutaneous melanoma peptide epitopes: correlation with T-cell receptor usage.
    Maeurer MJ; Hurd S; Martin DM; Storkus WJ; Lotze MT
    Cancer J Sci Am; 1995; 1(2):162-70. PubMed ID: 9166469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isolation of human tumor-specific antibodies by selection of an antibody phage library on melanoma cells.
    Kupsch JM; Tidman NH; Kang NV; Truman H; Hamilton S; Patel N; Newton Bishop JA; Leigh IM; Crowe JS
    Clin Cancer Res; 1999 Apr; 5(4):925-31. PubMed ID: 10213230
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative TCR:pMHC Dissociation Rate Assessment by NTAmers Reveals Antimelanoma T Cell Repertoires Enriched for High Functional Competence.
    Gannon PO; Wieckowski S; Baumgaertner P; Hebeisen M; Allard M; Speiser DE; Rufer N
    J Immunol; 2015 Jul; 195(1):356-66. PubMed ID: 26002978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Natural killer cells kill human melanoma cells with characteristics of cancer stem cells.
    Pietra G; Manzini C; Vitale M; Balsamo M; Ognio E; Boitano M; Queirolo P; Moretta L; Mingari MC
    Int Immunol; 2009 Jul; 21(7):793-801. PubMed ID: 19491215
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1.
    Sensi M; Traversari C; Radrizzani M; Salvi S; Maccalli C; Mortarini R; Rivoltini L; Farina C; Nicolini G; Wölfel T
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5674-8. PubMed ID: 7777568
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Study of the intracytoplasmatic antigens of malignant melanoma cells. Preliminary report].
    De Moragas J; Anguera A; Viñas J
    Actas Dermosifiliogr; 1971; 62(9):429-32. PubMed ID: 4949557
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of HC antibody in autologous tumor-specific cytotoxicity by human melanoma tumor-infiltrating lymphocytes.
    Mansfield PF; Salmeron MA; Rosenblum MG; Itoh K
    Int J Cancer; 1991 Sep; 49(3):356-61. PubMed ID: 1917133
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
    Carrel S; Schreyer M; Gross N; Zografos L
    Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
    Kokoschka EM
    Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559
    [No Abstract]   [Full Text] [Related]  

  • 58. Clonal variation in expression of a human melanoma antigen defined by a monoclonal antibody.
    Yeh MY; Hellström I; Hellström KE
    J Immunol; 1981 Apr; 126(4):1312-7. PubMed ID: 7009737
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antigens in ocular and cutaneous melanomas.
    Folberg R; Donoso LA; Herlyn MF; Koprowski H
    Am J Ophthalmol; 1983 Sep; 96(3):394-5. PubMed ID: 6351625
    [No Abstract]   [Full Text] [Related]  

  • 60. Expression of beta 1 integrins (very late antigens-4 and -5) on myeloma cells and clinical correlates in patients with multiple myeloma.
    Nishinarita S; Shimada H; Ito T; Namiki H; Kawahira H; Sawada U; Horie T
    J Int Med Res; 1998; 26(1):37-42. PubMed ID: 9513075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.